Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.

Kelly SuchmanYuying LuoAri Grinspan

Published in: Digestive diseases and sciences (2022)

Our study supports the efficacy and safety of FMT in immunocompromised patients, though future research is needed to further ascertain the potential effects of immunosuppression on FMT outcomes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
clostridium difficile
prognostic factors
respiratory failure
metabolic syndrome
intensive care unit
risk assessment
skeletal muscle
climate change
patient reported outcomes
extracorporeal membrane oxygenation